nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—Lisdexamfetamine—Lacosamide—epilepsy syndrome	0.142	0.365	CrCrCtD
Lisinopril—ABCB1—epilepsy syndrome	0.134	1	CbGaD
Lisinopril—Nateglinide—Lacosamide—epilepsy syndrome	0.126	0.325	CrCrCtD
Lisinopril—Aspartame—Lacosamide—epilepsy syndrome	0.12	0.309	CrCrCtD
Lisinopril—ABCB1—Levetiracetam—epilepsy syndrome	0.0409	0.208	CbGbCtD
Lisinopril—ABCB1—Clobazam—epilepsy syndrome	0.0283	0.144	CbGbCtD
Lisinopril—ABCB1—Lamotrigine—epilepsy syndrome	0.0273	0.139	CbGbCtD
Lisinopril—ABCB1—Carbamazepine—epilepsy syndrome	0.0235	0.12	CbGbCtD
Lisinopril—ABCB1—Phenytoin—epilepsy syndrome	0.0211	0.107	CbGbCtD
Lisinopril—ABCB1—Phenobarbital—epilepsy syndrome	0.0188	0.0957	CbGbCtD
Lisinopril—ABCB1—Midazolam—epilepsy syndrome	0.0185	0.0944	CbGbCtD
Lisinopril—ABCB1—Diazepam—epilepsy syndrome	0.0178	0.0907	CbGbCtD
Lisinopril—ACE—forelimb—epilepsy syndrome	0.00289	0.182	CbGeAlD
Lisinopril—ACE—autonomic nervous system—epilepsy syndrome	0.00282	0.177	CbGeAlD
Lisinopril—ACE—ganglion—epilepsy syndrome	0.00156	0.0982	CbGeAlD
Lisinopril—ACE2—head—epilepsy syndrome	0.00115	0.0721	CbGeAlD
Lisinopril—ACE2—nervous system—epilepsy syndrome	0.00109	0.0684	CbGeAlD
Lisinopril—ACE2—central nervous system—epilepsy syndrome	0.00105	0.0659	CbGeAlD
Lisinopril—Aspartame—TRPV1—epilepsy syndrome	0.000864	0.361	CrCbGaD
Lisinopril—ACE2—brain—epilepsy syndrome	0.000833	0.0523	CbGeAlD
Lisinopril—ACE—forebrain—epilepsy syndrome	0.000656	0.0412	CbGeAlD
Lisinopril—ACE—telencephalon—epilepsy syndrome	0.000603	0.0379	CbGeAlD
Lisinopril—Enalapril—SLCO1A2—epilepsy syndrome	0.000527	0.22	CrCbGaD
Lisinopril—ACE2—Peptide hormone metabolism—AGT—epilepsy syndrome	0.000435	0.00743	CbGpPWpGaD
Lisinopril—ABCB1—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	0.000433	0.00739	CbGpPWpGaD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.000433	0.00738	CbGpPWpGaD
Lisinopril—ACE—spinal cord—epilepsy syndrome	0.000423	0.0265	CbGeAlD
Lisinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A3—epilepsy syndrome	0.000422	0.0072	CbGpPWpGaD
Lisinopril—ABCB1—Abacavir transport and metabolism—ABCG2—epilepsy syndrome	0.000415	0.00707	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ERN1—epilepsy syndrome	0.000406	0.00692	CbGpPWpGaD
Lisinopril—ACE—head—epilepsy syndrome	0.000376	0.0236	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—POMC—epilepsy syndrome	0.000367	0.00625	CbGpPWpGaD
Lisinopril—ACE—nervous system—epilepsy syndrome	0.000356	0.0224	CbGeAlD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.000344	0.00586	CbGpPWpGaD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.000344	0.00586	CbGpPWpGaD
Lisinopril—ACE—central nervous system—epilepsy syndrome	0.000343	0.0215	CbGeAlD
Lisinopril—ACE2—Metabolism of proteins—EIF2AK3—epilepsy syndrome	0.000331	0.00564	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—NEU1—epilepsy syndrome	0.000331	0.00564	CbGpPWpGaD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	0.000319	0.00544	CbGpPWpGaD
Lisinopril—Nateglinide—KCNJ11—epilepsy syndrome	0.000318	0.133	CrCbGaD
Lisinopril—ACE—Peptide hormone metabolism—BCHE—epilepsy syndrome	0.000317	0.0054	CbGpPWpGaD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.000314	0.00536	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SLC4A10—epilepsy syndrome	0.000314	0.00536	CbGpPWpGaD
Lisinopril—Ramipril—BCHE—epilepsy syndrome	0.000312	0.13	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—PIGA—epilepsy syndrome	0.000308	0.00525	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—TPP1—epilepsy syndrome	0.000308	0.00525	CbGpPWpGaD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.000292	0.00498	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—EIF2B5—epilepsy syndrome	0.000289	0.00493	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—VDAC1—epilepsy syndrome	0.000281	0.0048	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ADD1—epilepsy syndrome	0.000274	0.00468	CbGpPWpGaD
Lisinopril—ACE—brain—epilepsy syndrome	0.000272	0.0171	CbGeAlD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.000267	0.00456	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.000267	0.00456	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.000267	0.00456	CbGpPWpGaD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.000257	0.00439	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ST3GAL3—epilepsy syndrome	0.000256	0.00437	CbGpPWpGaD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.000249	0.00424	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ST3GAL5—epilepsy syndrome	0.000246	0.00419	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.000245	0.00417	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ATP6AP2—epilepsy syndrome	0.000233	0.00398	CbGpPWpGaD
Lisinopril—ABCB1—forebrain—epilepsy syndrome	0.000231	0.0145	CbGeAlD
Lisinopril—ACE—Metabolism of proteins—PIGN—epilepsy syndrome	0.000213	0.00364	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PIGT—epilepsy syndrome	0.000213	0.00364	CbGpPWpGaD
Lisinopril—ABCB1—telencephalon—epilepsy syndrome	0.000212	0.0133	CbGeAlD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—PFKL—epilepsy syndrome	0.000205	0.0035	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.000203	0.00346	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.000203	0.00346	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.000203	0.00346	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—GOSR2—epilepsy syndrome	0.000195	0.00333	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—AGT—epilepsy syndrome	0.000195	0.00332	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.000193	0.0033	CbGpPWpGaD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	0.000192	0.00328	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	0.000183	0.00313	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ERN1—epilepsy syndrome	0.000181	0.00309	CbGpPWpGaD
Lisinopril—ABCB1—ABC-family proteins mediated transport—ABCC2—epilepsy syndrome	0.000175	0.00299	CbGpPWpGaD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	0.000169	0.00288	CbGpPWpGaD
Lisinopril—ABCB1—medulla oblongata—epilepsy syndrome	0.000167	0.0105	CbGeAlD
Lisinopril—ACE—Peptide hormone metabolism—POMC—epilepsy syndrome	0.000164	0.00279	CbGpPWpGaD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	0.000159	0.00272	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000158	0.00269	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—EIF2S1—epilepsy syndrome	0.000157	0.00269	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ACTB—epilepsy syndrome	0.000156	0.00265	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NT5E—epilepsy syndrome	0.000156	0.00265	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000154	0.00262	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000154	0.00262	CbGpPWpGaD
Lisinopril—ABCB1—midbrain—epilepsy syndrome	0.000153	0.00958	CbGeAlD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000152	0.0026	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000152	0.0026	CbGpPWpGaD
Lisinopril—ABCB1—spinal cord—epilepsy syndrome	0.000149	0.00934	CbGeAlD
Lisinopril—ACE—Metabolism of proteins—EIF2AK3—epilepsy syndrome	0.000148	0.00252	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—NEU1—epilepsy syndrome	0.000148	0.00252	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.00014	0.0024	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PIGA—epilepsy syndrome	0.000137	0.00234	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—TPP1—epilepsy syndrome	0.000137	0.00234	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000136	0.00232	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000136	0.00232	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000136	0.00232	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—BCHE—epilepsy syndrome	0.000134	0.00228	CbGpPWpGaD
Lisinopril—ABCB1—head—epilepsy syndrome	0.000132	0.0083	CbGeAlD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000131	0.00223	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—EIF2B5—epilepsy syndrome	0.000129	0.0022	CbGpPWpGaD
Lisinopril—Cilazapril—ABCB1—epilepsy syndrome	0.000126	0.0527	CrCbGaD
Lisinopril—ABCB1—nervous system—epilepsy syndrome	0.000125	0.00787	CbGeAlD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000124	0.00212	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ADD1—epilepsy syndrome	0.000122	0.00209	CbGpPWpGaD
Lisinopril—ABCB1—central nervous system—epilepsy syndrome	0.000121	0.00758	CbGeAlD
Lisinopril—ABCB1—cerebellum—epilepsy syndrome	0.000118	0.00741	CbGeAlD
Lisinopril—ACE2—Metabolism of proteins—PLAUR—epilepsy syndrome	0.000116	0.00199	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—epilepsy syndrome	0.000116	0.00198	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000115	0.00196	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—GDNF—epilepsy syndrome	0.000115	0.00195	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ST3GAL3—epilepsy syndrome	0.000114	0.00195	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000111	0.00189	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ST3GAL5—epilepsy syndrome	0.00011	0.00187	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000109	0.00185	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ATP6AP2—epilepsy syndrome	0.000104	0.00178	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000103	0.00176	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000103	0.00176	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000103	0.00176	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—epilepsy syndrome	9.98e-05	0.0017	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	9.9e-05	0.00169	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	9.83e-05	0.00168	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	9.83e-05	0.00168	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	9.7e-05	0.00166	CbGpPWpGaD
Lisinopril—ABCB1—brain—epilepsy syndrome	9.58e-05	0.00602	CbGeAlD
Lisinopril—Enalapril—ABCB1—epilepsy syndrome	9.27e-05	0.0387	CrCbGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—ABCG2—epilepsy syndrome	9.17e-05	0.00156	CbGpPWpGaD
Lisinopril—Nateglinide—CYP2D6—epilepsy syndrome	8.86e-05	0.037	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—AGT—epilepsy syndrome	8.22e-05	0.0014	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	8.01e-05	0.00137	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—EPO—epilepsy syndrome	7.86e-05	0.00134	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	7.81e-05	0.00133	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	7.81e-05	0.00133	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—NTF3—epilepsy syndrome	7.46e-05	0.00127	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	7.45e-05	0.00127	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—CXCL12—epilepsy syndrome	7.33e-05	0.00125	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—epilepsy syndrome	7.25e-05	0.00124	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	7.16e-05	0.00122	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	7.14e-05	0.00122	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	7.14e-05	0.00122	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	7.14e-05	0.00122	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	7.14e-05	0.00122	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—EIF2S1—epilepsy syndrome	7.03e-05	0.0012	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	7.01e-05	0.0012	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ACTB—epilepsy syndrome	6.95e-05	0.00118	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—POMC—epilepsy syndrome	6.92e-05	0.00118	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CCL2—epilepsy syndrome	6.77e-05	0.00115	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	6.64e-05	0.00113	CbGpPWpGaD
Lisinopril—Nateglinide—ALB—epilepsy syndrome	6.63e-05	0.0277	CrCbGaD
Lisinopril—ABCB1—Allograft Rejection—CXCL12—epilepsy syndrome	6.35e-05	0.00108	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	6.33e-05	0.00108	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CD40—epilepsy syndrome	6.27e-05	0.00107	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	6.24e-05	0.00106	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	6.07e-05	0.00104	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—BCHE—epilepsy syndrome	5.98e-05	0.00102	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HMOX1—epilepsy syndrome	5.96e-05	0.00102	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	5.84e-05	0.000997	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	5.83e-05	0.000995	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	5.64e-05	0.000962	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	5.64e-05	0.000962	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	5.41e-05	0.000923	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PLAUR—epilepsy syndrome	5.2e-05	0.000887	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	5.16e-05	0.000879	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	5.16e-05	0.000879	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	5.03e-05	0.000858	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	4.6e-05	0.000785	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	4.59e-05	0.000784	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	4.59e-05	0.000784	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	4.59e-05	0.000784	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	4.52e-05	0.000771	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	4.52e-05	0.000771	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	4.48e-05	0.000765	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—epilepsy syndrome	4.26e-05	0.000726	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	4.2e-05	0.000717	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—FOS—epilepsy syndrome	3.93e-05	0.00067	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.81e-05	0.00065	CbGpPWpGaD
Lisinopril—Dermatitis—Diazepam—epilepsy syndrome	3.74e-05	0.000182	CcSEcCtD
Lisinopril—Arthralgia—Pregabalin—epilepsy syndrome	3.72e-05	0.000182	CcSEcCtD
Lisinopril—Myalgia—Pregabalin—epilepsy syndrome	3.72e-05	0.000182	CcSEcCtD
Lisinopril—Chest pain—Pregabalin—epilepsy syndrome	3.72e-05	0.000182	CcSEcCtD
Lisinopril—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.72e-05	0.000181	CcSEcCtD
Lisinopril—Dizziness—Zonisamide—epilepsy syndrome	3.72e-05	0.000181	CcSEcCtD
Lisinopril—Headache—Diazepam—epilepsy syndrome	3.72e-05	0.000181	CcSEcCtD
Lisinopril—Anxiety—Pregabalin—epilepsy syndrome	3.71e-05	0.000181	CcSEcCtD
Lisinopril—Diarrhoea—Clonazepam—epilepsy syndrome	3.71e-05	0.000181	CcSEcCtD
Lisinopril—Anaemia—Gabapentin—epilepsy syndrome	3.7e-05	0.000181	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.7e-05	0.00018	CcSEcCtD
Lisinopril—Hypotension—Valproic Acid—epilepsy syndrome	3.69e-05	0.00018	CcSEcCtD
Lisinopril—Asthenia—Carbamazepine—epilepsy syndrome	3.69e-05	0.00018	CcSEcCtD
Lisinopril—Diarrhoea—Phenytoin—epilepsy syndrome	3.68e-05	0.00018	CcSEcCtD
Lisinopril—Discomfort—Pregabalin—epilepsy syndrome	3.68e-05	0.000179	CcSEcCtD
Lisinopril—Nausea—Fosphenytoin—epilepsy syndrome	3.67e-05	0.000179	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	3.67e-05	0.000626	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—AGT—epilepsy syndrome	3.67e-05	0.000626	CbGpPWpGaD
Lisinopril—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.66e-05	0.000179	CcSEcCtD
Lisinopril—Erythema multiforme—Topiramate—epilepsy syndrome	3.66e-05	0.000179	CcSEcCtD
Lisinopril—Angioedema—Gabapentin—epilepsy syndrome	3.66e-05	0.000179	CcSEcCtD
Lisinopril—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.66e-05	0.000178	CcSEcCtD
Lisinopril—Vomiting—Felbamate—epilepsy syndrome	3.65e-05	0.000178	CcSEcCtD
Lisinopril—Dry mouth—Pregabalin—epilepsy syndrome	3.64e-05	0.000178	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.64e-05	0.00062	CbGpPWpGaD
Lisinopril—Pruritus—Carbamazepine—epilepsy syndrome	3.64e-05	0.000177	CcSEcCtD
Lisinopril—Rash—Felbamate—epilepsy syndrome	3.62e-05	0.000177	CcSEcCtD
Lisinopril—Dermatitis—Felbamate—epilepsy syndrome	3.62e-05	0.000177	CcSEcCtD
Lisinopril—Malaise—Gabapentin—epilepsy syndrome	3.61e-05	0.000176	CcSEcCtD
Lisinopril—Tinnitus—Topiramate—epilepsy syndrome	3.61e-05	0.000176	CcSEcCtD
Lisinopril—Vertigo—Gabapentin—epilepsy syndrome	3.6e-05	0.000176	CcSEcCtD
Lisinopril—Headache—Felbamate—epilepsy syndrome	3.6e-05	0.000176	CcSEcCtD
Lisinopril—Confusional state—Pregabalin—epilepsy syndrome	3.6e-05	0.000175	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.6e-05	0.000175	CcSEcCtD
Lisinopril—Flushing—Topiramate—epilepsy syndrome	3.6e-05	0.000175	CcSEcCtD
Lisinopril—Syncope—Gabapentin—epilepsy syndrome	3.59e-05	0.000175	CcSEcCtD
Lisinopril—Leukopenia—Gabapentin—epilepsy syndrome	3.59e-05	0.000175	CcSEcCtD
Lisinopril—Dizziness—Clonazepam—epilepsy syndrome	3.58e-05	0.000175	CcSEcCtD
Lisinopril—Nausea—Vigabatrin—epilepsy syndrome	3.58e-05	0.000175	CcSEcCtD
Lisinopril—Vomiting—Zonisamide—epilepsy syndrome	3.58e-05	0.000174	CcSEcCtD
Lisinopril—Insomnia—Valproic Acid—epilepsy syndrome	3.57e-05	0.000174	CcSEcCtD
Lisinopril—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.57e-05	0.000174	CcSEcCtD
Lisinopril—Oedema—Pregabalin—epilepsy syndrome	3.57e-05	0.000174	CcSEcCtD
Lisinopril—Asthenia—Lamotrigine—epilepsy syndrome	3.56e-05	0.000174	CcSEcCtD
Lisinopril—Dizziness—Phenytoin—epilepsy syndrome	3.56e-05	0.000174	CcSEcCtD
Lisinopril—Rash—Zonisamide—epilepsy syndrome	3.55e-05	0.000173	CcSEcCtD
Lisinopril—Infection—Pregabalin—epilepsy syndrome	3.54e-05	0.000173	CcSEcCtD
Lisinopril—Paraesthesia—Valproic Acid—epilepsy syndrome	3.54e-05	0.000173	CcSEcCtD
Lisinopril—Palpitations—Gabapentin—epilepsy syndrome	3.54e-05	0.000173	CcSEcCtD
Lisinopril—Dermatitis—Zonisamide—epilepsy syndrome	3.54e-05	0.000173	CcSEcCtD
Lisinopril—Dizziness—Oxcarbazepine—epilepsy syndrome	3.54e-05	0.000173	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	3.53e-05	0.000603	CbGpPWpGaD
Lisinopril—Nausea—Diazepam—epilepsy syndrome	3.53e-05	0.000172	CcSEcCtD
Lisinopril—Loss of consciousness—Gabapentin—epilepsy syndrome	3.52e-05	0.000172	CcSEcCtD
Lisinopril—Headache—Zonisamide—epilepsy syndrome	3.52e-05	0.000172	CcSEcCtD
Lisinopril—Dyspnoea—Valproic Acid—epilepsy syndrome	3.52e-05	0.000172	CcSEcCtD
Lisinopril—Diarrhoea—Carbamazepine—epilepsy syndrome	3.52e-05	0.000172	CcSEcCtD
Lisinopril—Angiopathy—Topiramate—epilepsy syndrome	3.51e-05	0.000171	CcSEcCtD
Lisinopril—Pruritus—Lamotrigine—epilepsy syndrome	3.51e-05	0.000171	CcSEcCtD
Lisinopril—Shock—Pregabalin—epilepsy syndrome	3.51e-05	0.000171	CcSEcCtD
Lisinopril—Somnolence—Valproic Acid—epilepsy syndrome	3.51e-05	0.000171	CcSEcCtD
Lisinopril—Cough—Gabapentin—epilepsy syndrome	3.5e-05	0.000171	CcSEcCtD
Lisinopril—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.49e-05	0.00017	CcSEcCtD
Lisinopril—Mediastinal disorder—Topiramate—epilepsy syndrome	3.49e-05	0.00017	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	3.48e-05	0.000594	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	3.48e-05	0.000594	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	3.48e-05	0.000594	CbGpPWpGaD
Lisinopril—Tachycardia—Pregabalin—epilepsy syndrome	3.48e-05	0.00017	CcSEcCtD
Lisinopril—Chills—Topiramate—epilepsy syndrome	3.48e-05	0.00017	CcSEcCtD
Lisinopril—Dyspepsia—Valproic Acid—epilepsy syndrome	3.47e-05	0.000169	CcSEcCtD
Lisinopril—Skin disorder—Pregabalin—epilepsy syndrome	3.47e-05	0.000169	CcSEcCtD
Lisinopril—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.45e-05	0.000168	CcSEcCtD
Lisinopril—Vomiting—Clonazepam—epilepsy syndrome	3.45e-05	0.000168	CcSEcCtD
Lisinopril—Decreased appetite—Valproic Acid—epilepsy syndrome	3.43e-05	0.000167	CcSEcCtD
Lisinopril—Alopecia—Topiramate—epilepsy syndrome	3.42e-05	0.000167	CcSEcCtD
Lisinopril—Vomiting—Phenytoin—epilepsy syndrome	3.42e-05	0.000167	CcSEcCtD
Lisinopril—Rash—Clonazepam—epilepsy syndrome	3.42e-05	0.000167	CcSEcCtD
Lisinopril—Dermatitis—Clonazepam—epilepsy syndrome	3.41e-05	0.000167	CcSEcCtD
Lisinopril—Chest pain—Gabapentin—epilepsy syndrome	3.41e-05	0.000166	CcSEcCtD
Lisinopril—Myalgia—Gabapentin—epilepsy syndrome	3.41e-05	0.000166	CcSEcCtD
Lisinopril—Arthralgia—Gabapentin—epilepsy syndrome	3.41e-05	0.000166	CcSEcCtD
Lisinopril—Nausea—Felbamate—epilepsy syndrome	3.41e-05	0.000166	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.41e-05	0.000166	CcSEcCtD
Lisinopril—Vomiting—Oxcarbazepine—epilepsy syndrome	3.4e-05	0.000166	CcSEcCtD
Lisinopril—Fatigue—Valproic Acid—epilepsy syndrome	3.4e-05	0.000166	CcSEcCtD
Lisinopril—Anxiety—Gabapentin—epilepsy syndrome	3.4e-05	0.000166	CcSEcCtD
Lisinopril—Anorexia—Pregabalin—epilepsy syndrome	3.4e-05	0.000166	CcSEcCtD
Lisinopril—Dizziness—Carbamazepine—epilepsy syndrome	3.4e-05	0.000166	CcSEcCtD
Lisinopril—Diarrhoea—Lamotrigine—epilepsy syndrome	3.4e-05	0.000166	CcSEcCtD
Lisinopril—Headache—Clonazepam—epilepsy syndrome	3.39e-05	0.000166	CcSEcCtD
Lisinopril—Rash—Phenytoin—epilepsy syndrome	3.39e-05	0.000166	CcSEcCtD
Lisinopril—Mental disorder—Topiramate—epilepsy syndrome	3.39e-05	0.000166	CcSEcCtD
Lisinopril—Dermatitis—Phenytoin—epilepsy syndrome	3.39e-05	0.000165	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.39e-05	0.000165	CcSEcCtD
Lisinopril—Rash—Oxcarbazepine—epilepsy syndrome	3.38e-05	0.000165	CcSEcCtD
Lisinopril—Constipation—Valproic Acid—epilepsy syndrome	3.37e-05	0.000165	CcSEcCtD
Lisinopril—Pain—Valproic Acid—epilepsy syndrome	3.37e-05	0.000165	CcSEcCtD
Lisinopril—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.37e-05	0.000165	CcSEcCtD
Lisinopril—Headache—Phenytoin—epilepsy syndrome	3.37e-05	0.000165	CcSEcCtD
Lisinopril—Erythema—Topiramate—epilepsy syndrome	3.37e-05	0.000165	CcSEcCtD
Lisinopril—Malnutrition—Topiramate—epilepsy syndrome	3.37e-05	0.000165	CcSEcCtD
Lisinopril—Discomfort—Gabapentin—epilepsy syndrome	3.37e-05	0.000164	CcSEcCtD
Lisinopril—Headache—Oxcarbazepine—epilepsy syndrome	3.35e-05	0.000164	CcSEcCtD
Lisinopril—Nausea—Zonisamide—epilepsy syndrome	3.34e-05	0.000163	CcSEcCtD
Lisinopril—Dry mouth—Gabapentin—epilepsy syndrome	3.34e-05	0.000163	CcSEcCtD
Lisinopril—Hypotension—Pregabalin—epilepsy syndrome	3.33e-05	0.000163	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CASP8—epilepsy syndrome	3.33e-05	0.000567	CbGpPWpGaD
Lisinopril—Flatulence—Topiramate—epilepsy syndrome	3.32e-05	0.000162	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	3.32e-05	0.000567	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	3.32e-05	0.000567	CbGpPWpGaD
Lisinopril—Tension—Topiramate—epilepsy syndrome	3.31e-05	0.000161	CcSEcCtD
Lisinopril—Dysgeusia—Topiramate—epilepsy syndrome	3.3e-05	0.000161	CcSEcCtD
Lisinopril—Confusional state—Gabapentin—epilepsy syndrome	3.3e-05	0.000161	CcSEcCtD
Lisinopril—Dizziness—Lamotrigine—epilepsy syndrome	3.28e-05	0.00016	CcSEcCtD
Lisinopril—Nervousness—Topiramate—epilepsy syndrome	3.28e-05	0.00016	CcSEcCtD
Lisinopril—Oedema—Gabapentin—epilepsy syndrome	3.27e-05	0.00016	CcSEcCtD
Lisinopril—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.27e-05	0.00016	CcSEcCtD
Lisinopril—Vomiting—Carbamazepine—epilepsy syndrome	3.27e-05	0.000159	CcSEcCtD
Lisinopril—Back pain—Topiramate—epilepsy syndrome	3.26e-05	0.000159	CcSEcCtD
Lisinopril—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.25e-05	0.000159	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.25e-05	0.000159	CcSEcCtD
Lisinopril—Infection—Gabapentin—epilepsy syndrome	3.25e-05	0.000159	CcSEcCtD
Lisinopril—Muscle spasms—Topiramate—epilepsy syndrome	3.24e-05	0.000158	CcSEcCtD
Lisinopril—Rash—Carbamazepine—epilepsy syndrome	3.24e-05	0.000158	CcSEcCtD
Lisinopril—Dermatitis—Carbamazepine—epilepsy syndrome	3.24e-05	0.000158	CcSEcCtD
Lisinopril—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.23e-05	0.000157	CcSEcCtD
Lisinopril—Insomnia—Pregabalin—epilepsy syndrome	3.23e-05	0.000157	CcSEcCtD
Lisinopril—Nausea—Clonazepam—epilepsy syndrome	3.22e-05	0.000157	CcSEcCtD
Lisinopril—Headache—Carbamazepine—epilepsy syndrome	3.22e-05	0.000157	CcSEcCtD
Lisinopril—Shock—Gabapentin—epilepsy syndrome	3.22e-05	0.000157	CcSEcCtD
Lisinopril—Paraesthesia—Pregabalin—epilepsy syndrome	3.2e-05	0.000156	CcSEcCtD
Lisinopril—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.2e-05	0.000156	CcSEcCtD
Lisinopril—Nausea—Phenytoin—epilepsy syndrome	3.2e-05	0.000156	CcSEcCtD
Lisinopril—Tachycardia—Gabapentin—epilepsy syndrome	3.19e-05	0.000156	CcSEcCtD
Lisinopril—Dyspnoea—Pregabalin—epilepsy syndrome	3.18e-05	0.000155	CcSEcCtD
Lisinopril—Nausea—Oxcarbazepine—epilepsy syndrome	3.18e-05	0.000155	CcSEcCtD
Lisinopril—Vision blurred—Topiramate—epilepsy syndrome	3.18e-05	0.000155	CcSEcCtD
Lisinopril—Skin disorder—Gabapentin—epilepsy syndrome	3.18e-05	0.000155	CcSEcCtD
Lisinopril—Somnolence—Pregabalin—epilepsy syndrome	3.17e-05	0.000155	CcSEcCtD
Lisinopril—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.16e-05	0.000154	CcSEcCtD
Lisinopril—Tremor—Topiramate—epilepsy syndrome	3.16e-05	0.000154	CcSEcCtD
Lisinopril—Vomiting—Lamotrigine—epilepsy syndrome	3.16e-05	0.000154	CcSEcCtD
Lisinopril—Urticaria—Valproic Acid—epilepsy syndrome	3.13e-05	0.000153	CcSEcCtD
Lisinopril—Rash—Lamotrigine—epilepsy syndrome	3.13e-05	0.000153	CcSEcCtD
Lisinopril—Ill-defined disorder—Topiramate—epilepsy syndrome	3.13e-05	0.000153	CcSEcCtD
Lisinopril—Dermatitis—Lamotrigine—epilepsy syndrome	3.13e-05	0.000153	CcSEcCtD
Lisinopril—Abdominal pain—Valproic Acid—epilepsy syndrome	3.12e-05	0.000152	CcSEcCtD
Lisinopril—Body temperature increased—Valproic Acid—epilepsy syndrome	3.12e-05	0.000152	CcSEcCtD
Lisinopril—Anorexia—Gabapentin—epilepsy syndrome	3.12e-05	0.000152	CcSEcCtD
Lisinopril—Anaemia—Topiramate—epilepsy syndrome	3.12e-05	0.000152	CcSEcCtD
Lisinopril—Headache—Lamotrigine—epilepsy syndrome	3.11e-05	0.000152	CcSEcCtD
Lisinopril—Decreased appetite—Pregabalin—epilepsy syndrome	3.1e-05	0.000151	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—POMC—epilepsy syndrome	3.09e-05	0.000527	CbGpPWpGaD
Lisinopril—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.08e-05	0.00015	CcSEcCtD
Lisinopril—Fatigue—Pregabalin—epilepsy syndrome	3.08e-05	0.00015	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	3.07e-05	0.000524	CbGpPWpGaD
Lisinopril—Hypotension—Gabapentin—epilepsy syndrome	3.06e-05	0.000149	CcSEcCtD
Lisinopril—Nausea—Carbamazepine—epilepsy syndrome	3.05e-05	0.000149	CcSEcCtD
Lisinopril—Pain—Pregabalin—epilepsy syndrome	3.05e-05	0.000149	CcSEcCtD
Lisinopril—Constipation—Pregabalin—epilepsy syndrome	3.05e-05	0.000149	CcSEcCtD
Lisinopril—Malaise—Topiramate—epilepsy syndrome	3.04e-05	0.000148	CcSEcCtD
Lisinopril—Vertigo—Topiramate—epilepsy syndrome	3.03e-05	0.000148	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—CCL2—epilepsy syndrome	3.02e-05	0.000516	CbGpPWpGaD
Lisinopril—Syncope—Topiramate—epilepsy syndrome	3.02e-05	0.000148	CcSEcCtD
Lisinopril—Leukopenia—Topiramate—epilepsy syndrome	3.02e-05	0.000147	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.99e-05	0.00051	CbGpPWpGaD
Lisinopril—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.98e-05	0.000145	CcSEcCtD
Lisinopril—Palpitations—Topiramate—epilepsy syndrome	2.98e-05	0.000145	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.96e-05	0.000506	CbGpPWpGaD
Lisinopril—Loss of consciousness—Topiramate—epilepsy syndrome	2.96e-05	0.000145	CcSEcCtD
Lisinopril—Insomnia—Gabapentin—epilepsy syndrome	2.96e-05	0.000144	CcSEcCtD
Lisinopril—Nausea—Lamotrigine—epilepsy syndrome	2.95e-05	0.000144	CcSEcCtD
Lisinopril—Cough—Topiramate—epilepsy syndrome	2.94e-05	0.000144	CcSEcCtD
Lisinopril—Feeling abnormal—Pregabalin—epilepsy syndrome	2.94e-05	0.000143	CcSEcCtD
Lisinopril—Paraesthesia—Gabapentin—epilepsy syndrome	2.94e-05	0.000143	CcSEcCtD
Lisinopril—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.92e-05	0.000142	CcSEcCtD
Lisinopril—Dyspnoea—Gabapentin—epilepsy syndrome	2.92e-05	0.000142	CcSEcCtD
Lisinopril—Somnolence—Gabapentin—epilepsy syndrome	2.91e-05	0.000142	CcSEcCtD
Lisinopril—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.91e-05	0.000142	CcSEcCtD
Lisinopril—Dyspepsia—Gabapentin—epilepsy syndrome	2.88e-05	0.00014	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.87e-05	0.00049	CbGpPWpGaD
Lisinopril—Chest pain—Topiramate—epilepsy syndrome	2.87e-05	0.00014	CcSEcCtD
Lisinopril—Arthralgia—Topiramate—epilepsy syndrome	2.87e-05	0.00014	CcSEcCtD
Lisinopril—Myalgia—Topiramate—epilepsy syndrome	2.87e-05	0.00014	CcSEcCtD
Lisinopril—Anxiety—Topiramate—epilepsy syndrome	2.86e-05	0.00014	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.85e-05	0.000139	CcSEcCtD
Lisinopril—Decreased appetite—Gabapentin—epilepsy syndrome	2.84e-05	0.000139	CcSEcCtD
Lisinopril—ABCB1—Metabolism—CA13—epilepsy syndrome	2.84e-05	0.000484	CbGpPWpGaD
Lisinopril—Discomfort—Topiramate—epilepsy syndrome	2.84e-05	0.000138	CcSEcCtD
Lisinopril—Urticaria—Pregabalin—epilepsy syndrome	2.83e-05	0.000138	CcSEcCtD
Lisinopril—Asthenia—Valproic Acid—epilepsy syndrome	2.83e-05	0.000138	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.82e-05	0.000138	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—JUN—epilepsy syndrome	2.82e-05	0.000481	CbGpPWpGaD
Lisinopril—Fatigue—Gabapentin—epilepsy syndrome	2.82e-05	0.000138	CcSEcCtD
Lisinopril—Abdominal pain—Pregabalin—epilepsy syndrome	2.82e-05	0.000138	CcSEcCtD
Lisinopril—Body temperature increased—Pregabalin—epilepsy syndrome	2.82e-05	0.000138	CcSEcCtD
Lisinopril—Dry mouth—Topiramate—epilepsy syndrome	2.81e-05	0.000137	CcSEcCtD
Lisinopril—Pain—Gabapentin—epilepsy syndrome	2.8e-05	0.000136	CcSEcCtD
Lisinopril—Constipation—Gabapentin—epilepsy syndrome	2.8e-05	0.000136	CcSEcCtD
Lisinopril—Pruritus—Valproic Acid—epilepsy syndrome	2.79e-05	0.000136	CcSEcCtD
Lisinopril—Confusional state—Topiramate—epilepsy syndrome	2.77e-05	0.000135	CcSEcCtD
Lisinopril—Oedema—Topiramate—epilepsy syndrome	2.75e-05	0.000134	CcSEcCtD
Lisinopril—Infection—Topiramate—epilepsy syndrome	2.73e-05	0.000133	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	2.71e-05	0.000462	CbGpPWpGaD
Lisinopril—Shock—Topiramate—epilepsy syndrome	2.71e-05	0.000132	CcSEcCtD
Lisinopril—Diarrhoea—Valproic Acid—epilepsy syndrome	2.7e-05	0.000132	CcSEcCtD
Lisinopril—Feeling abnormal—Gabapentin—epilepsy syndrome	2.7e-05	0.000132	CcSEcCtD
Lisinopril—Thrombocytopenia—Topiramate—epilepsy syndrome	2.69e-05	0.000131	CcSEcCtD
Lisinopril—Tachycardia—Topiramate—epilepsy syndrome	2.69e-05	0.000131	CcSEcCtD
Lisinopril—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.67e-05	0.00013	CcSEcCtD
Lisinopril—Skin disorder—Topiramate—epilepsy syndrome	2.67e-05	0.00013	CcSEcCtD
Lisinopril—Hyperhidrosis—Topiramate—epilepsy syndrome	2.66e-05	0.00013	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	2.64e-05	0.00045	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	2.64e-05	0.00045	CbGpPWpGaD
Lisinopril—Hypersensitivity—Pregabalin—epilepsy syndrome	2.63e-05	0.000128	CcSEcCtD
Lisinopril—Anorexia—Topiramate—epilepsy syndrome	2.62e-05	0.000128	CcSEcCtD
Lisinopril—Dizziness—Valproic Acid—epilepsy syndrome	2.61e-05	0.000127	CcSEcCtD
Lisinopril—Urticaria—Gabapentin—epilepsy syndrome	2.6e-05	0.000127	CcSEcCtD
Lisinopril—Body temperature increased—Gabapentin—epilepsy syndrome	2.59e-05	0.000126	CcSEcCtD
Lisinopril—Abdominal pain—Gabapentin—epilepsy syndrome	2.59e-05	0.000126	CcSEcCtD
Lisinopril—Hypotension—Topiramate—epilepsy syndrome	2.57e-05	0.000125	CcSEcCtD
Lisinopril—Asthenia—Pregabalin—epilepsy syndrome	2.56e-05	0.000125	CcSEcCtD
Lisinopril—Pruritus—Pregabalin—epilepsy syndrome	2.52e-05	0.000123	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL1B—epilepsy syndrome	2.52e-05	0.00043	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	2.52e-05	0.000429	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	2.52e-05	0.000429	CbGpPWpGaD
Lisinopril—Vomiting—Valproic Acid—epilepsy syndrome	2.51e-05	0.000122	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.51e-05	0.000122	CcSEcCtD
Lisinopril—Insomnia—Topiramate—epilepsy syndrome	2.49e-05	0.000121	CcSEcCtD
Lisinopril—Rash—Valproic Acid—epilepsy syndrome	2.49e-05	0.000121	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	2.49e-05	0.000424	CbGpPWpGaD
Lisinopril—Dermatitis—Valproic Acid—epilepsy syndrome	2.49e-05	0.000121	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	2.48e-05	0.000422	CbGpPWpGaD
Lisinopril—Headache—Valproic Acid—epilepsy syndrome	2.47e-05	0.000121	CcSEcCtD
Lisinopril—Paraesthesia—Topiramate—epilepsy syndrome	2.47e-05	0.000121	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	2.47e-05	0.000421	CbGpPWpGaD
Lisinopril—Dyspnoea—Topiramate—epilepsy syndrome	2.45e-05	0.00012	CcSEcCtD
Lisinopril—Somnolence—Topiramate—epilepsy syndrome	2.45e-05	0.000119	CcSEcCtD
Lisinopril—Diarrhoea—Pregabalin—epilepsy syndrome	2.44e-05	0.000119	CcSEcCtD
Lisinopril—Dyspepsia—Topiramate—epilepsy syndrome	2.42e-05	0.000118	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	2.41e-05	0.000412	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	2.41e-05	0.000412	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	2.41e-05	0.000412	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	2.41e-05	0.000412	CbGpPWpGaD
Lisinopril—Hypersensitivity—Gabapentin—epilepsy syndrome	2.41e-05	0.000118	CcSEcCtD
Lisinopril—Decreased appetite—Topiramate—epilepsy syndrome	2.39e-05	0.000117	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.38e-05	0.000116	CcSEcCtD
Lisinopril—Fatigue—Topiramate—epilepsy syndrome	2.37e-05	0.000116	CcSEcCtD
Lisinopril—Dizziness—Pregabalin—epilepsy syndrome	2.36e-05	0.000115	CcSEcCtD
Lisinopril—Pain—Topiramate—epilepsy syndrome	2.35e-05	0.000115	CcSEcCtD
Lisinopril—Constipation—Topiramate—epilepsy syndrome	2.35e-05	0.000115	CcSEcCtD
Lisinopril—Asthenia—Gabapentin—epilepsy syndrome	2.35e-05	0.000114	CcSEcCtD
Lisinopril—Nausea—Valproic Acid—epilepsy syndrome	2.34e-05	0.000114	CcSEcCtD
Lisinopril—Pruritus—Gabapentin—epilepsy syndrome	2.31e-05	0.000113	CcSEcCtD
Lisinopril—Vomiting—Pregabalin—epilepsy syndrome	2.27e-05	0.000111	CcSEcCtD
Lisinopril—Feeling abnormal—Topiramate—epilepsy syndrome	2.27e-05	0.000111	CcSEcCtD
Lisinopril—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.25e-05	0.00011	CcSEcCtD
Lisinopril—Rash—Pregabalin—epilepsy syndrome	2.25e-05	0.00011	CcSEcCtD
Lisinopril—Dermatitis—Pregabalin—epilepsy syndrome	2.25e-05	0.00011	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	2.24e-05	0.000383	CbGpPWpGaD
Lisinopril—Diarrhoea—Gabapentin—epilepsy syndrome	2.24e-05	0.000109	CcSEcCtD
Lisinopril—Headache—Pregabalin—epilepsy syndrome	2.23e-05	0.000109	CcSEcCtD
Lisinopril—Urticaria—Topiramate—epilepsy syndrome	2.19e-05	0.000107	CcSEcCtD
Lisinopril—Body temperature increased—Topiramate—epilepsy syndrome	2.18e-05	0.000106	CcSEcCtD
Lisinopril—Abdominal pain—Topiramate—epilepsy syndrome	2.18e-05	0.000106	CcSEcCtD
Lisinopril—Dizziness—Gabapentin—epilepsy syndrome	2.16e-05	0.000106	CcSEcCtD
Lisinopril—ABCB1—Metabolism—CERS1—epilepsy syndrome	2.15e-05	0.000367	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	2.15e-05	0.000367	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ADK—epilepsy syndrome	2.15e-05	0.000367	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—FAR1—epilepsy syndrome	2.15e-05	0.000367	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PDXK—epilepsy syndrome	2.15e-05	0.000367	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GLUD1—epilepsy syndrome	2.15e-05	0.000367	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.14e-05	0.000365	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	2.14e-05	0.000364	CbGpPWpGaD
Lisinopril—Nausea—Pregabalin—epilepsy syndrome	2.12e-05	0.000103	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.11e-05	0.00036	CbGpPWpGaD
Lisinopril—Vomiting—Gabapentin—epilepsy syndrome	2.08e-05	0.000101	CcSEcCtD
Lisinopril—Rash—Gabapentin—epilepsy syndrome	2.06e-05	0.000101	CcSEcCtD
Lisinopril—Dermatitis—Gabapentin—epilepsy syndrome	2.06e-05	0.000101	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.05e-05	0.00035	CbGpPWpGaD
Lisinopril—Headache—Gabapentin—epilepsy syndrome	2.05e-05	0.0001	CcSEcCtD
Lisinopril—Hypersensitivity—Topiramate—epilepsy syndrome	2.03e-05	9.89e-05	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.98e-05	0.000337	CbGpPWpGaD
Lisinopril—Asthenia—Topiramate—epilepsy syndrome	1.97e-05	9.63e-05	CcSEcCtD
Lisinopril—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	1.97e-05	0.000336	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—EPM2A—epilepsy syndrome	1.97e-05	0.000336	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PNPO—epilepsy syndrome	1.97e-05	0.000336	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GAMT—epilepsy syndrome	1.97e-05	0.000336	CbGpPWpGaD
Lisinopril—Pruritus—Topiramate—epilepsy syndrome	1.95e-05	9.5e-05	CcSEcCtD
Lisinopril—Nausea—Gabapentin—epilepsy syndrome	1.94e-05	9.48e-05	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.91e-05	0.000325	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.91e-05	0.000325	CbGpPWpGaD
Lisinopril—Diarrhoea—Topiramate—epilepsy syndrome	1.88e-05	9.19e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.88e-05	0.000321	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	1.83e-05	0.000312	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—QDPR—epilepsy syndrome	1.83e-05	0.000312	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CA4—epilepsy syndrome	1.83e-05	0.000312	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.83e-05	0.000312	CbGpPWpGaD
Lisinopril—Dizziness—Topiramate—epilepsy syndrome	1.82e-05	8.88e-05	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.8e-05	0.000306	CbGpPWpGaD
Lisinopril—Vomiting—Topiramate—epilepsy syndrome	1.75e-05	8.54e-05	CcSEcCtD
Lisinopril—Rash—Topiramate—epilepsy syndrome	1.74e-05	8.47e-05	CcSEcCtD
Lisinopril—Dermatitis—Topiramate—epilepsy syndrome	1.73e-05	8.46e-05	CcSEcCtD
Lisinopril—Headache—Topiramate—epilepsy syndrome	1.72e-05	8.41e-05	CcSEcCtD
Lisinopril—ABCB1—Metabolism—COX3—epilepsy syndrome	1.72e-05	0.000293	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.7e-05	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.64e-05	0.00028	CbGpPWpGaD
Lisinopril—Nausea—Topiramate—epilepsy syndrome	1.63e-05	7.97e-05	CcSEcCtD
Lisinopril—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.63e-05	0.000278	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.63e-05	0.000278	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.63e-05	0.000278	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.63e-05	0.000278	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.63e-05	0.000278	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.57e-05	0.000268	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.56e-05	0.000265	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.52e-05	0.000259	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.49e-05	0.000254	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.49e-05	0.000254	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.49e-05	0.000254	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.48e-05	0.000253	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.44e-05	0.000245	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.41e-05	0.00024	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.39e-05	0.000237	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.39e-05	0.000237	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.34e-05	0.000228	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.3e-05	0.000222	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.29e-05	0.00022	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.27e-05	0.000216	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.24e-05	0.000212	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.24e-05	0.000211	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.24e-05	0.000211	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.23e-05	0.00021	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.21e-05	0.000206	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.18e-05	0.000201	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.18e-05	0.000201	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.15e-05	0.000197	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.13e-05	0.000193	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.11e-05	0.000189	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.09e-05	0.000186	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.08e-05	0.000185	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.05e-05	0.00018	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.02e-05	0.000174	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.01e-05	0.000172	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1e-05	0.000171	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AQP1—epilepsy syndrome	9.88e-06	0.000169	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	9.03e-06	0.000154	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CHRM3—epilepsy syndrome	8.94e-06	0.000152	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	8.94e-06	0.000152	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ABCG2—epilepsy syndrome	7.28e-06	0.000124	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	7.1e-06	0.000121	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	7.06e-06	0.00012	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	6.72e-06	0.000115	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	6.37e-06	0.000109	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.07e-06	0.000104	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	6.06e-06	0.000103	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—BCHE—epilepsy syndrome	6.04e-06	0.000103	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	5.76e-06	9.82e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLCB1—epilepsy syndrome	5.7e-06	9.71e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TH—epilepsy syndrome	5.68e-06	9.68e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HMOX1—epilepsy syndrome	4.74e-06	8.08e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CAT—epilepsy syndrome	4.67e-06	7.97e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPX1—epilepsy syndrome	4.23e-06	7.21e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AGT—epilepsy syndrome	3.71e-06	6.32e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOE—epilepsy syndrome	3.63e-06	6.19e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—POMC—epilepsy syndrome	3.12e-06	5.32e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALB—epilepsy syndrome	2.84e-06	4.85e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.49e-06	4.24e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.25e-06	2.13e-05	CbGpPWpGaD
